Synthorx, Inc. (THOR) Return on Investment ROI from the third quarter of 2019 to third quarter of 2018 and for the year 2019, average high and low, overall ranking from Sep 30 2019 to Jun 30 2018 - CSIMarket
CSIMarket
 


Synthorx, Inc.  (NASDAQ: THOR)


Synthorx,'s ROI from its third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Synthorx,'s ROI in the third quarter of 2019?
Synthorx, Inc. recorded a cumulative net loss of $-58 million during 12 months ending in the third quarter of 2019, resulting in a negative return on investment (ROI) of -33.79%.

Within the Healthcare sector 262 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2019 from 2501 to 3268.

Definition and Formula of Return on Investment



Return On Investment (Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
Y / Y Investment Change TTM -75.84 % -55.09 % -36.62 % -19.74 % -0.42 %
Y / Y Net Income Change TTM - - - - 50.61 %
Investment (TTM) in Millions 155 166 177 184 734
Return On Investment (TTM) -33.79 % -15.69 % -8.77 % -2.65 % 2.52 %
THOR's Overall Ranking # 3268 # 2501 # 1203 # #
Seq. Investment Change TTM -45.87 % -29.63 % -21.99 % -18.68 % 0.6 %
Seq. Net Income Change TTM - - - - -47.05 %
Net Income (TTM) in Millions -58 -49 -39 -15 18




Return On Investment THOR's Ranking
Within: No.
Industry # 87
Sector # 263
Overall # 3268

Return On Investment Statistics
High Average Low
9.01 %
4.8 %
-7.2 %
(Jun 28 2014)   (Sep 30 2019)







Financial Statements
Synthorx,'s III. Quarter Investments $ 155 Millions THOR's Balance sheet
Synthorx,'s III. Quarter Income $ -12 Millions Quarterly THOR's Income Statement
THOR's Income by Division See THOR's Income by Division


THOR Annual Return On Investment (Jan 03 2015)
2014
(Dec 28 2013)
2013
(Dec 29 2012)
2012
(Dec 31 2011)
2011
(Jan 03 2009)
2010
Total Investments in Millions 683 717 630 638 689
Y / Y Investment Growth -4.86 % 13.93 % -1.27 % -7.46 % -
Net Income in Millions 50 73 56 72 18
Y / Y Net Income Growth -31.28 % 30.56 % -21.5 % 290.29 % -
Annual Return On Investment 7.38 % 10.22 % 8.92 % 11.22 % 2.66 %


Annual Roi Comment
In the fiscal year 2014 ROI decreased relative to the previous year to 7.38 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
THOR's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for THOR's Competitors
Subscribers only: Roi for Synthorx,'s Suppliers
Subscribers only: Return On Investment for THOR's Customers

Other Ratios
THOR's Roa THOR's Inventory Turnover Ratio THOR's Growth Rates THOR's Dividend Statistics
THOR's Profitability Ratios THOR's Asset Turnover Ratio THOR's Dividend Growth
THOR's Roe THOR's Valuation Ratios THOR's Financial Strength Ratios THOR's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2019, within Healthcare Sector ROI


Date modified: 2026-09-08T15:09:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.